Trials / Not Yet Recruiting
Not Yet RecruitingNCT07504887
Effects of Aerobic Exercise in Rheumatoid Arthritis
Evaluation of the Effects of Aerobic Exercise Therapy on Quality of Life, Functional Capacity, Mood, Fatigue, and Inflammatory Markers in Patients With Rheumatoid Arthritis
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Kutahya Health Sciences University · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effects of aerobic exercise therapy on quality of life, functional capacity, mood, and fatigue in patients with rheumatoid arthritis. Additionally, the study investigates the impact of aerobic exercise on inflammatory markers, pain, and disease activity.
Detailed description
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by joint inflammation, pain, and functional limitations. Exercise therapy is widely used in rehabilitation to improve functional capacity and quality of life in RA patients. In this study, patients with low disease activity RA will be divided into two groups: Standard medical treatment + education Standard medical treatment + education + aerobic exercise The aerobic exercise program will be conducted 5 days per week for 6 weeks. Outcomes including functional capacity (VO2 max), quality of life, fatigue, mood, and inflammatory markers will be assessed before and after the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard Medical Care (SMC) | Standard medical treatment |
| OTHER | Patient Education | Patient education |
| OTHER | Aerobic Exercise Group | Frequency: 5 days/week Duration: 6 weeks (30 sessions) Exercise intensity: 50-70% of Wmax Includes warm-up, aerobic phase, and cool-down |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-12-31
- Completion
- 2027-01-30
- First posted
- 2026-04-01
- Last updated
- 2026-04-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07504887. Inclusion in this directory is not an endorsement.